Marfrig Global Foods (MBRF3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
7 Jul, 2026Executive summary
Achieved record consolidated EBITDA of R$3.5 billion and net income of R$94 million in 3Q25, with highest sales volumes since 2022 and strong execution of value-creation and synergy strategies.
Launched Sadia Halal, the world's largest halal chicken company, with assets valued at US$2.07 billion and a planned IPO in Saudi Arabia, reinforcing geographic and product diversification.
Distributed R$3.8 billion in dividends and interest on capital, reflecting strong shareholder returns.
Completed the acquisition of Gelprime to expand value-added product portfolio in gelatin and collagen.
Advanced integration and synergy capture post-merger, with significant organizational adjustments and efficiency programs.
Financial highlights
Net revenue reached R$41.8 billion in 3Q25, up 9.2% year-over-year; operating cash flow was R$3.3 billion.
Adjusted EBITDA was R$3.5 billion (8.4% margin), down 8.6% year-over-year; net income was R$94 million, a 62% decrease year-over-year.
Free cash flow (excluding BRF share purchases) was R$555 million; Capex for the quarter was R$1.4 billion.
Net leverage ratio at 3.09x (BRL) and 3.31x (USD); net debt at R$41.3 billion, up 10% from 2Q25.
Gross margin at 12.3%; SG&A as % of revenue at 8.4% (down 0.5 p.p. y/y).
Outlook and guidance
Management expects to capture R$1 billion in synergies from the merger, with R$600 million in 2026 and the rest by 2028.
Sadia Halal IPO targeted for 2026/2027 in Riyadh to unlock further value in the high-growth protein market.
Focus on innovation, operational excellence, ESG leadership, and continued pursuit of efficiency gains.
Lower interest rates projected to reduce debt service by over R$500 million in 2026.
Positive demand outlook for beef and poultry, with balanced global supply and demand expected for 2026.
Latest events from Marfrig Global Foods
- Record revenue, EBITDA, and dividends in 2024, with lower leverage and strong BRF results.MBRF3
Q4 202410 Jul 2026 - Net revenue rose 12.4% to R$37.7B, EBITDA up 60.4%, leverage down to 3.0x, and major asset sales completed.MBRF3
Q3 202410 Jul 2026 - Net revenue rose 16.5% and adjusted EBITDA 64.8% in 2Q24, led by BRF and South America.MBRF3
Q2 202410 Jul 2026 - Record revenue and volumes in 2025, led by merger synergies, South America, and global expansion.MBRF3
Q4 20258 Jul 2026 - Net revenue up 27% to R$38.6B, with strong EBITDA and improved leverage.MBRF3
Q1 20258 Jul 2026 - Net revenue rose 8.6% to R$37.8B, with solid EBITDA and BRF merger approval.MBRF3
Q2 20257 Jul 2026 - Net income up 26.8% year-over-year, driven by global demand and integration synergies.MBRF3
Q1 202620 May 2026